Lota Zoth S.'s Insider Trades & SAST Disclosures
Lota Zoth S.'s most recent trade in 89bio Inc was a trade of 56,400 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Lota Zoth S..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 89bio Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 56,400 | 56,400 | - | - | Stock Option (Right to Buy) | |
| enGene Holdings Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2024 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Lumos Pharma Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 3,328 | 3,328 | - | - | Stock Option (Right to Buy) | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 2,917 | 2,917 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 2,167 | 2,167 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,166 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,166 | 6,559 (0%) | 0% | - | Common Stock | |
| enGene Holdings Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Lota Zoth S. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 45,150 | 45,150 | - | - | Stock Option (Right to Buy) | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Sale of securities on an exchange or to another person at price $ 0.56 per share. | 05 Jun 2023 | 5,700 | 52,716 (0%) | 0% | 0.6 | 3,192 | Common Stock |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 35,000 | 35,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 26,000 | 26,000 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 19,000 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 19,000 | 58,416 (0%) | 0% | - | Common Stock | |
| Lumos Pharma Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 3,345 | 3,345 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 27,400 | 27,400 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 28,000 | 28,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 19,000 | 19,000 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 18,000 | 43,016 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 18,000 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Sale of securities on an exchange or to another person at price $ 1.98 per share. | 13 May 2022 | 3,600 | 39,416 (0%) | 0% | 2.0 | 7,128 | Common Stock |
| Lumos Pharma Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 3,431 | 3,431 | - | - | Stock Option (Right to Buy) | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 4,090 | 25,977 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 4,090 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Sale of securities on an exchange or to another person at price $ 5.01 per share. | 03 Jan 2022 | 961 | 25,016 (0%) | 0% | 5.0 | 4,815 | Common Stock |
| Lumos Pharma Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 2,910 | 2,910 | - | - | Stock Option (Right to Buy) | |
| Lumos Pharma Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 367 | 2,187 (0%) | 0% | 0 | Common Stock | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 27,000 | 27,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 18,000 | 18,000 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2021 | 8,700 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2021 | 8,700 | 23,932 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Sale of securities on an exchange or to another person at price $ 6.62 per share. | 13 May 2021 | 2,045 | 21,887 (0%) | 0% | 6.6 | 13,538 | Common Stock |
| 89bio Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2021 | 4,090 | 16,193 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2021 | 4,090 | 4,090 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Sale of securities on an exchange or to another person at price $ 9.48 per share. | 03 Jan 2021 | 961 | 15,232 (0%) | 0% | 9.5 | 9,110 | Common Stock |
| 89bio Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2020 | 13,300 | 13,300 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2020 | 8,700 | 8,700 | - | - | Restricted Stock Unit | |
| Zymeworks BC Inc | Lota S. Zoth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2020 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2020 | 8,013 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Lota S. Zoth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2020 | 8,013 | 12,103 (0%) | 0% | - | Common Stock | |
| Lumos Pharma Inc | Lota S. Zoth | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 5,684 | 5,684 | - | - | Stock Option (Right to Buy) | |
| Lumos Pharma Inc | Lota S. Zoth | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 709 | 1,820 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges